NYSE · HOSPITAL & MEDICAL SERVICE PLANS · LARGE CAP
The Cigna Group CI
10 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY5 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$274.9B
▲ 11.2% vs FY2024
Dividend streak
5 yrs
Raised every year since 2021
EPS · FY25
$22.18
Dividend / sh · FY25
$6.04
Payout · FY25
27%
ROE · FY25
14.4%
Net margin · FY25
2.2%
Dividend coverage
3.7×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 274.9B
Revenue, FY2025 · full 10-year series below
Revenue
Net income
2 cents of every revenue dollar became profit this year.
Per share
USD 22.18
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 3.7 times — the rest stayed in the company.
Profitability
14.4%
Return on equity, FY2025
ROE
Operating margin3.3%
Net margin2.2%
Return on assets3.8%
Each USD of equity produced 14 cents of profit this year.
Returned to shareholders
USD 5.0B
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 1.6B
Net buybacksUSD 3.4B
Share of profit84.4%
Consecutive raises5 years
USD 1.6B in dividends and USD 3.4B in buybacks — 84% of the year's profit went back to shareholders.
Growth
+11.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+15.0%
+11.4%
Net income
−4.2%
−6.8%
EPS, diluted
+1.2%
−0.7%
Dividend / share
+10.5%
+172.8%
Returned to shareholders
−16.4%
+6.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.26B
Shares outstanding, FY2025
Change, 5 years−25.7%
Change, 10 years—
The share count shrank 26% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 157.9B
total assets, end of FY2025
Total assetsUSD 157.9B
EquityUSD 41.7B
CashUSD 7.7B
Gross debtUSD 31.5B
Net debtUSD 23.8B
Current ratio0.85×
Net debt stands at 57% of equity.
History
10 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue $B
274.9
247.1
195.3
180.5
174.1
160.4
153.6
48.6
41.8
39.8
Operating income $B
9.2
9.4
8.5
8.4
7.9
8.2
8.1
4.2
3.9
3.1
EBITDA $B
12.0
12.2
11.6
11.4
10.9
11.0
11.7
4.9
4.5
3.7
Income tax $B
1.5
1.5
0.1
1.6
1.4
2.4
1.4
0.9
1.4
1.1
Net income $B
6.0
3.4
5.2
6.8
5.4
8.5
5.1
2.6
2.2
1.8
EPS, diluted $
22.18
12.12
17.39
21.41
15.75
22.96
13.44
10.54
8.77
7.19
Dividend / sh $
6.04
5.60
4.92
4.48
4.00
0.04
0.04
0.04
0.04
·
Payout %
27
46
28
20
25
0
0
·
·
·
ROE %
14.4
7.9
11.4
14.8
11.1
17.7
11.9
9.7
16.3
·
Shares out B
0.26
0.27
0.29
0.30
0.32
0.35
0.37
0.38
0.00
0.00
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
28 of 28
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed